Kazia Therapeutics Ltd (KZA) - Financial and Strategic SWOT Analysis Review

Kazia Therapeutics Ltd (KZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by it to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Kazia Therapeutics Limited (Kazia Therapeutics), is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs. It develops its products based on three drug technology platforms, phosphoinositide 3-kinase (PI3K) inhibitors, anti-tropomyosins (ATM) and super-benzopyrans (SBP). ATM drugs that target the cancer cell cytoskeleton are being developed for the treatment of melanoma, prostate cancer and neuroblastoma. SBP drugs that target cancer stem cells are being developed for the treatment of ovarian cancer and glioblastoma. The PI3K inhibitor functions by inhibiting an important signaling pathway which is critical to the development of certain kinds of tumors. The companys product pipeline includes PI3K GDC-0084; Cantrixil (TRX-E-002-1). Kazia is headquartered in New South Wales, Australia.

Kazia Therapeutics Ltd Key Recent Developments

Feb 19,2018: Kazia Change Of Registered Office And Business Address
Aug 29,2017: Novogen Annual Report And Full-year Financial Results
Aug 14,2017: Novogen: Board Review Of Business Operations And Governance
Jun 08,2017: Novogen Streamlines Board and Costs
Mar 10,2017: Novogen Announces Transformation to a Clinical Stage Organisation Leads to Changes in Management Structure

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Kazia Therapeutics Ltd - Key Facts 5
Kazia Therapeutics Ltd - Key Employees 6
Kazia Therapeutics Ltd - Key Employee Biographies 7
Kazia Therapeutics Ltd - Major Products and Services 8
Kazia Therapeutics Ltd - History 9
Kazia Therapeutics Ltd - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 Company Analysis 13
Company Overview 13
Kazia Therapeutics Ltd - Business Description 14
Kazia Therapeutics Ltd - Corporate Strategy 15
Kazia Therapeutics Ltd - SWOT Analysis 16
SWOT Analysis - Overview 16
Kazia Therapeutics Ltd - Strengths 16
Kazia Therapeutics Ltd - Weaknesses 17
Kazia Therapeutics Ltd - Opportunities 18
Kazia Therapeutics Ltd - Threats 19
Kazia Therapeutics Ltd - Key Competitors 20
Section 3 Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 Companys Lifesciences Financial Deals and Alliances 27
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Kazia Therapeutics Ltd, Recent Deals Summary 29
Section 5 Companys Recent Developments 30
Feb 19, 2018: Kazia Change Of Registered Office And Business Address 30
Aug 29, 2017: Novogen Annual Report And Full-year Financial Results 31
Aug 14, 2017: Novogen: Board Review Of Business Operations And Governance 33
Jun 08, 2017: Novogen Streamlines Board and Costs 34
Mar 10, 2017: Novogen Announces Transformation to a Clinical Stage Organisation Leads to Changes in Management Structure 35
Mar 10, 2017: Novogen: Transformation To A Clinical Stage Organisation Leads To Changes In Management Structure 36
Section 6 Appendix 37
Methodology 37
Ratio Definitions 37
About GlobalData 41
Contact Us 41
Disclaimer 41

List Of Tables


Kazia Therapeutics Ltd, Key Facts 5
Kazia Therapeutics Ltd, Key Employees 6
Kazia Therapeutics Ltd, Key Employee Biographies 7
Kazia Therapeutics Ltd, Major Products and Services 8
Kazia Therapeutics Ltd, History 9
Kazia Therapeutics Ltd, Subsidiaries 12
Kazia Therapeutics Ltd, Key Competitors 20
Kazia Therapeutics Ltd, Ratios based on current share price 21
Kazia Therapeutics Ltd, Annual Ratios 22
Kazia Therapeutics Ltd, Annual Ratios (Cont...1) 23
Kazia Therapeutics Ltd, Interim Ratios 25
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Kazia Therapeutics Ltd, Recent Deals Summary 29
Currency Codes 37
Capital Market Ratios 37
Equity Ratios 38
Profitability Ratios 38
Cost Ratios 39
Liquidity Ratios 39
Leverage Ratios 40
Efficiency Ratios 40

List Of Figures


Kazia Therapeutics Ltd, Performance Chart (2014 - 2018) 24
Kazia Therapeutics Ltd, Ratio Charts 26
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Kazia Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

Kazia Therapeutics Ltd (KZA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kazia Therapeutics Limited (Kazia Therapeutics), is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs. It develops its products based on three drug technology

USD 250 View Report

Kazia Therapeutics Ltd (KZA) - Financial and Strategic SWOT Analysis Review

Kazia Therapeutics Ltd (KZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Kazia Therapeutics Ltd (KZA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kazia Therapeutics Limited (Kazia Therapeutics), is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs. It develops its products based on three drug technology

USD 250 View Report

Iksuda Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Iksuda Therapeutics Ltd (Iksuda), formerly Glythera Ltd is a biotechnology company that focuses on the development of antibody drug conjugates (ADCs) and biotherapeutics for the treatment of cancer. The company

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available